Royal Bank of Canada
BIOA

Royal Bank of Canada’s BioAge Labs BIOA Stock Holding History

Royal Bank of Canada’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26K Buy
+1,070
New +$19.3K ﹤0.01% 6182
2026
Q1 		– Sell
-640
Closed -$9K – 7797
2025
Q4 		$9K Sell
640
-14,744
-96% -$131K ﹤0.01% 6493
2025
Q3 		$91K Buy
15,384
+12,843
+505% +$60.1K ﹤0.01% 5562
2025
Q2 		$11K Buy
2,541
+1,442
+131% +$5.81K ﹤0.01% 6463
2025
Q1 		$4K Sell
1,099
-74,809
-99% -$346K ﹤0.01% 6445
2024
Q4 		$440K Buy
+75,908
New +$1.31M ﹤0.01% 4175

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Royal Bank of Canada's BIOA Position: Q2 2026 in Review

Royal Bank of Canada opened a new position in BioAge Labs (BIOA) in Q2 2026: 1,070 shares worth $26K. The stake represents ﹤0.01% of the portfolio and ranks #6182 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in BIOA as recently as Q4 2025.

Royal Bank of Canada first reported a position in BIOA in Q4 2024 and has held it in 6 quarters since. The position peaked at $440K in Q4 2024. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Royal Bank of Canada held 1,070 shares of BioAge Labs worth $26K as of Q2 2026.
  • BioAge Labs was a new Royal Bank of Canada position in Q2 2026.
  • BioAge Labs made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6182 holding.
  • Royal Bank of Canada first reported a position in BioAge Labs in Q4 2024 and has held it in 6 quarters since.
  • Royal Bank of Canada's BioAge Labs position peaked at $440K in Q4 2024.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.